Ian Davis

@profiand.bsky.social

10 months ago

#ENZAMET @anzuptrials.bsky.social #NHMRCTrialsCentre #ASCO25
✅ 50% survival at 8yr vs 40% - sustained, all subgroups
✅ non- #ProstateCancer #pcsm deaths same in both arms: removes doubts of long term safety and benefit re competing causes of death
✅ undetectable PSA is good; more likely with enza

Ian Davis

@profiand.bsky.social

10 months ago

#BCGMM presented by Dickon Hayne at #ASCO25. Simple question, hard trial, needed a cooperative group like @anzuptrials.bsky.social #NHMRCTrialsCentre. Discussant John Sfakianos very enthusiastic, one of the most impactful #NMIBC trials he has seen, will change his practice. #BladderCancer #blcsm